Skip to content
Skip to main navigation
Skip to first column
Skip to second column

Delcath Systems, Inc. - pr0900008-3

Home

CLINICAL TRIALS

Current Trials

Click on map for full list

Trial Centers

Phase III Trial Centers

CALIFORNIA John Wayne Cancer Institute Dr. Mark Faries (310) 582-7020 This e-mail address is being protected from spambots. You need JavaScript enabled to view it	COLORADO Swedish Medical Center Dr. Charles Nutting (303) 806-7418 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
FLORIDA Moffitt Cancer Center Dr. Jonathan Zager (813) 745-1085 This e-mail address is being protected from spambots. You need JavaScript enabled to view it	MARYLAND National Cancer Institute Dr. Marybeth Hughes (301) 451-6940 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
MARYLAND University of Maryland Dr. Richard Alexander (410) 328-7680 This e-mail address is being protected from spambots. You need JavaScript enabled to view it	NEW JERSEY Morristown Memorial Hospital Dr. Eric Whitman (973) 971-7111 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
NEW YORK Albany Medical Center Dr. Gary Siskin (518) 262-5356 This e-mail address is being protected from spambots. You need JavaScript enabled to view it	OHIO Ohio State University Dr. Mark Bloomston (614) 293-4583 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
OREGON Providence Health Systems Dr. Walter Urba (503) 215-2691 This e-mail address is being protected from spambots. You need JavaScript enabled to view it	PENNSYLVANIA St. Luke's Cancer Center Dr. Sanjiv Agarwala (610) 954-2145 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
TEXAS University of Texas Medical Branch Dr. Orhan Ozkan (409) 772-9202 This e-mail address is being protected from spambots. You need JavaScript enabled to view it	PENNSYLVANIA University of Pittsburgh Medical Center Dr. James Pingpank (412) 692-2852 This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Phase II Trial Centers

MARYLAND
National Cancer Institute
Dr. Marybeth Hughes
(301) 451-6940
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Phase II - Trials

Phase II - Treatment of the following tumors in the liver with Melphalan: hepatocellular carcinoma (primary liver cancer), metastatic adenocarcinomas and neuroendocrine tumors in the liver and metastatic ocular and cutaneous melanoma that received prior regional Melphalan therapy; taking place at the National Cancer Institute

Phase III - Treatment of Metastatic Melanoma

Phase III - Treatment of Metastatic Melanoma in the Liver (Ocular and Cutaneous) with Melphalan, taking place at the National Cancer Institute, University of Maryland Medical Center, Albany Medical Center, St. Luke’s Cancer Center of Bethlehem, Morristown Memorial Hospital, University of Texas Medical Branch, Moffitt Cancer Center, John Wayne Cancer Center, Providence Health Systems and Swedish medical Center.

News Alerts

Latest News